BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1086 related articles for article (PubMed ID: 16393224)

  • 21. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H; Schulick RD; Choti MA; Pawlik TM
    Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S; Yeganeh M; Nguyen K; Durazo F; Han S; Yersiz H; Farmer DG; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2009 Nov; 15(11):1525-34. PubMed ID: 19877207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
    Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C
    Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.
    Vakili K; Pomposelli JJ; Cheah YL; Akoad M; Lewis WD; Khettry U; Gordon F; Khwaja K; Jenkins R; Pomfret EA
    Liver Transpl; 2009 Dec; 15(12):1861-6. PubMed ID: 19938113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria.
    Yao FY; Ferrell L; Bass NM; Bacchetti P; Ascher NL; Roberts JP
    Liver Transpl; 2002 Sep; 8(9):765-74. PubMed ID: 12200775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
    Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
    Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Merli M; Nicolini G; Gentili F; Novelli G; Iappelli M; Casciaro G; Di Tondo U; Pecorella I; Marasco A; Onetti Muda A; Nudo F; Mennini G; Ginanni Corradini S; Riggio O; Berloco P; Attili AF; Rossi M
    Transplant Proc; 2005; 37(6):2535-40. PubMed ID: 16182736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma.
    Yokoi H; Isaji S; Yamagiwa K; Tabata M; Nemoto A; Sakurai H; Usui M; Uemoto S
    J Hepatobiliary Pancreat Surg; 2006; 13(2):123-30. PubMed ID: 16547673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival after liver transplantation in patients with hepatocellular carcinoma.
    Iwatsuki S; Marsh JW; Starzl TE
    Princess Takamatsu Symp; 1995; 25():271-6. PubMed ID: 8875633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
    Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
    Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Milan criteria versus San Francisco criteria in hepatocellular carcinoma: our center's experience.
    Sánchez Antolín G; García Pajares F; Pérez E; Villacastín E; Ruiz Rebollo L; Sánchez DP; Cítores MA; Velicia Llames R
    Transplant Proc; 2009 Apr; 41(3):1012-3. PubMed ID: 19376413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.
    Lee HH; Joh JW; Park JH; Lee KW; Heo JS; Choi SH; Kim SJ; Lee SK
    Transplant Proc; 2005 Mar; 37(2):1251-3. PubMed ID: 15848686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year survival of patients with hepatocellular carcinoma treated with laparoscopic microwave coagulation therapy.
    Seki S; Sakaguchi H; Iwai S; Kadoya H; Kabayashi S; Kitada T; Fujii H; Tanaka T
    Endoscopy; 2005 Dec; 37(12):1220-5. PubMed ID: 16329021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.
    Llovet JM; Bruix J; Fuster J; Castells A; Garcia-Valdecasas JC; Grande L; Franca A; Brú C; Navasa M; Ayuso MC; Solé M; Real MI; Vilana R; Rimola A; Visa J; Rodés J
    Hepatology; 1998 Jun; 27(6):1572-7. PubMed ID: 9620329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era.
    Levi DM; Tzakis AG; Martin P; Nishida S; Island E; Moon J; Selvaggi G; Tekin A; Madrazo BL; Narayanan G; Garcia MT; Feun LG; Tryphonopoulos P; Skartsis N; Livingstone AS
    J Am Coll Surg; 2010 May; 210(5):727-34, 735-6. PubMed ID: 20421039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.